Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$0.53 - $0.93 $2,855 - $5,009
5,387 Added 8.54%
68,440 $39,000
Q4 2023

Feb 14, 2024

BUY
$0.63 - $1.14 $11,055 - $20,004
17,548 Added 38.56%
63,053 $52,000
Q3 2023

Nov 13, 2023

BUY
$1.12 - $1.88 $997 - $1,675
891 Added 2.0%
45,505 $51,000
Q2 2023

Aug 10, 2023

BUY
$1.31 - $2.04 $11,475 - $17,870
8,760 Added 24.43%
44,614 $71,000
Q1 2023

May 11, 2023

SELL
$1.45 - $2.95 $4,845 - $9,858
-3,342 Reduced 8.53%
35,854 $54,000
Q4 2022

Feb 02, 2023

BUY
$2.02 - $3.25 $16,164 - $26,006
8,002 Added 25.65%
39,196 $94,000
Q3 2022

Nov 04, 2022

BUY
$1.96 - $3.14 $1,669 - $2,675
852 Added 2.81%
31,194 $64,000
Q2 2022

Aug 01, 2022

SELL
$1.3 - $2.64 $13,984 - $28,398
-10,757 Reduced 26.17%
30,342 $59,000
Q1 2022

May 10, 2022

SELL
$2.35 - $3.47 $15,947 - $23,547
-6,786 Reduced 14.17%
41,099 $101,000
Q4 2021

Feb 08, 2022

BUY
$2.92 - $5.74 $62,514 - $122,887
21,409 Added 80.86%
47,885 $155,000
Q3 2021

Nov 12, 2021

SELL
$4.98 - $6.63 $122,846 - $163,548
-24,668 Reduced 48.23%
26,476 $139,000
Q2 2021

Aug 13, 2021

BUY
$2.56 - $5.49 $23,352 - $50,079
9,122 Added 21.71%
51,144 $281,000
Q1 2021

May 14, 2021

BUY
$2.69 - $5.25 $19,322 - $37,710
7,183 Added 20.62%
42,022 $114,000
Q4 2020

Feb 09, 2021

BUY
$3.17 - $4.49 $51,483 - $72,922
16,241 Added 87.33%
34,839 $111,000
Q3 2020

Nov 13, 2020

SELL
$2.98 - $5.2 $643 - $1,123
-216 Reduced 1.15%
18,598 $74,000
Q2 2020

Aug 03, 2020

BUY
$2.29 - $4.24 $43,084 - $79,771
18,814 New
18,814 $74,000
Q1 2020

May 15, 2020

SELL
$1.92 - $4.39 $27,855 - $63,690
-14,508 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$2.41 - $4.4 $5,583 - $10,194
2,317 Added 19.01%
14,508 $59,000
Q3 2019

Nov 12, 2019

BUY
$2.17 - $3.14 $26,454 - $38,279
12,191 New
12,191 $31,000
Q2 2019

Aug 13, 2019

SELL
$2.53 - $3.04 $25,378 - $30,494
-10,031 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$2.51 - $3.73 $25,177 - $37,415
10,031 New
10,031 $30,000
Q4 2018

Feb 14, 2019

SELL
$1.59 - $2.66 $16,938 - $28,336
-10,653 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$1.59 - $2.42 $193 - $295
122 Added 1.16%
10,653 $23,000
Q2 2018

Aug 13, 2018

BUY
$2.26 - $4.65 $23,800 - $48,969
10,531 New
10,531 $24,000
Q1 2018

May 14, 2018

SELL
$3.51 - $6.04 $38,939 - $67,007
-11,094 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.78 $36,166 - $53,029
11,094
11,094 $36,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.